Literature DB >> 303163

DDMP and selective folinic acid protection in the treatment of malignant disease: a further report.

L A Price, B T Hill, J H Goldie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 303163

Source DB:  PubMed          Journal:  Clin Oncol        ISSN： 0305-7399


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy of malignant melanoma.

Authors:  R S Benjamin
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).

Authors:  R de Jager; D Dupont; J J Rodzynek; C Dorlet; G Lagrange
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.

Authors:  R de Jager; A Brugarolas; M Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Kinetics of metoprine, a lipid-soluble antifolate.

Authors:  B R Jones; C S Gordon; J Umans; M M Reidenberg; C W Young
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.